Sirolimus for Nosebleeds in HHT

NCT05269849 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hereditary Hemorrhagic Telangiectasia
Nosebleeds
Epistaxis

Interventions

DRUG: Sirolimus

Sponsor

Unity Health Toronto

Collaborators

[object Object]
[object Object]